"Designing Growth Strategies is in our DNA"
The global laboratory informatics market size was valued at USD 4.11 billion in 2024. The market is projected to grow from USD 4.29 billion in 2025 to USD 7.19 billion by 2032, exhibiting a CAGR of 7.64% during the forecast period. North america dominated the laboratory informatics market with a market share of 49.14% in 2024.
Laboratory informatics is based on information technology for the management and optimization of laboratory data, workflows, and operations. It involves use of software and different systems for the improvisation of data accuracy, ensuring compliance, and streamlining processes in various settings. Prominent factors such as growing adoption of automation & digital transformation, and integration of AI, machine learning & analytics, and others are supporting the upward trajectory of the market.
Furthermore, the market encompasses several major players such as Thermo Fisher Scientific Inc., LabVantage Solutions Inc., and LabWare, among others. A wide range of product portfolio coupled with strong geographic expansion have supported the dominance of these companies in the global market.
Growing Adoption of Automation & Digital Transformation to Drive Market Growth
One of the prominent growth drivers in the laboratory informatics industry is the growing adoption of automation & digital transformation. The increasing number of laboratories are shifting toward fully automated and paperless workflows instead of traditional, manual, and paper-based processes. This transformation has reduced human errors along with improvements in efficiency, accuracy, and turnaround time. This has especially enhanced operations in data-intensive works such as drug discovery, genomics, and clinical testing. The integration of laboratory informatics platforms with instruments, robotics, and AI-based tools allows seamless data capture, analysis, and reporting. This in turn enhances productivity and regulatory compliance.
High Implementation & Maintenance Costs to Restrict Market Expansion
One of the major restraints in the global laboratory informatics market is the high cost of implementation and maintenance. This factor significantly impacts the adoption of these products and services by small and mid-sized laboratories. The integration of advanced solutions such as LIMS, ELN, or SDMS usually requires substantial upfront investment in hardware, software, customization, and validation. In addition, ongoing expenses related to training, upgrades, technical support, and periodic maintenance further increase the total cost. This financial burden often prevents smaller organizations, research labs, and labs in emerging economies from adopting these systems, despite their long-term efficiency benefits.
Integration of Artificial Intelligence to Create Lucrative Growth Opportunities
The integration of artificial intelligence is anticipated to create promising growth opportunities in the market. Advanced analytics and AI-driven informatics platforms can transform raw lab data into predictive insights, supporting drug discovery, clinical decision-making, and quality assurance. This presents a strong opportunity for vendors offering AI-enabled tools. This enhances research productivity along with reducing the cost and time required for bringing new therapies to market.
Adoption of Cloud-Based & SaaS Solutions is a Significant Market Trends
The rapid adoption of cloud-based and SaaS (software-as-a-service) solutions is one of the key trends in the market. Cloud and software-as-a-service delivery reduce infrastructure cost, enable remote access, and simplify updates and scalability, boosting adoption especially in newer laboratories. Laboratories are increasingly shifting away from on-premise deployments toward cloud-hosted platforms due to their several advantages including scalability, flexibility, and lower upfront costs. Moreover, cloud systems enhance data security, compliance, and integration with other digital tools, making them a preferred choice.
Complex Integration of with Traditional Systems to Hamper Market Growth
A key challenge in the global market is the complex integration of new systems with already present infrastructure. Several laboratories, particularly in pharmaceuticals and academic research, still rely on fragmented IT setups, traditional instruments, or paper-based workflows. Thus, migrating or replacing them is costly and disruptive, which results in slower product adoption. Furthermore, mismatched data formats and the lack of standardized protocols across labs make the integration process technically complex, in turn challenging the global laboratory informatics market growth.
Download Free sample to learn more about this report.
High Adoption of Laboratory Information Management Systems (LIMS) Contributed to Segment Growth
On the basis of the product, the market is classified into laboratory information management systems (LIMS), electronic lab notebooks (ELN), scientific data management systems (SDMS), laboratory execution systems (LES), enterprise content management (ECM), and others.
The laboratory information management systems (LIMS) segment accounted for the largest global laboratory informatics market share in 2024. The increasing adoption of these systems owing to its wide range of functions, important role in workflow management, and other factors has primarily driven the segment growth. In addition, LIMS platforms help laboratories comply with strict regulatory frameworks such as FDA EMA, HIPAA, and GLP/GMP. Its ability to generate audit trails, electronic signatures, and traceability records positions it as the primary informatics tool in regulated industries. Additionally, increasing new product launches also supplements the segment growth.
To know how our report can help streamline your business, Speak to Analyst
Growing Shift toward Outsourcing Contributed to Segmental Growth
On the basis of component, the market is segmented into individual software and services.
The services segment captured the dominating share of the market in 2024. The increasing shift toward outsourcing of laboratory informatics, and rising adoption of cloud-based LIMS and ELNs have majorly driven the segment growth. Moreover, presence of well-established companies in offering these services also supplements the segment growth.
The software segment is expected to grow at a CAGR of 6.65% over the study period.
Advantages Offered by Capsules Supplemented Segmental Growth
In terms of deployment, the market is divided into cloud-based, web-based, and on-premise.
The on-premise segment held the leading share of the market in 2024. This can be attributed to the strict compliance with regulations and preferred in-house control over sensitive data by key end users such as pharmaceutical companies. On-premise systems also offered greater customization, direct security control, and integration with legacy instruments. Owing to these factors, the segment dominated the overall market.
The cloud-based segment is expected to grow at a CAGR of 11.73% over the forecast years.
Increasing Focus on Research Fuels Segmental Growth
In terms of application, the market is categorized into R&D and experiment documentation, quality assurance/compliance, clinical trial data & patient data management, and others.
The R&D and experiment documentation segment is anticipated to dominate the market over the forecast period. Heavy influx of investment for research and development activities by pharmaceutical and biotechnology companies, and increasing demand for advanced solutions to capture, organize, and analyze experimental results have contributed to the dominance of the segment. Additionally, the growing focus on data integrity and innovation is also fueling demand for products in this application.
The quality assurance/compliance segment is expected to witness 6.76% growth over the forecast period.
High Investments in R&D by Pharmaceutical & Biotechnology Industries Propelled Segment Growth
Based on end user, the market is segmented into pharmaceutical & biotechnology industries, CROs & CDMOs, and others.
In terms of end user, in 2024 pharmaceutical & biotechnology industries held the dominating share of the global market. This owing to their increasing investments in research & development, rising adoption of advanced products for data management, and strong reliance on lab informatics solutions. Furthermore, the segment is set to hold a market share of 59.7% share in 2025.
In addition, the CROs & CDMOs segment is projected to grow at a CAGR of 11.07% during the forecast period.
By region, the market is divided into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.
North America captured the dominating share of the global market in 2023 valuing at USD 2.00 billion and also took the leading share in 2024 with USD 2.02 billion. The dominance of the region can be attributed to the factors such high demand for cloud-based solutions, active involvement in innovative drug development by pharmaceutical companies, and advanced healthcare infrastructure. In 2025, the U.S. market is estimated to reach USD 1.91 billion. The country’s market growth is driven by increased R&D, the need for data management and regulatory compliance, and the adoption of cloud-based and AI-integrated systems.
North America Laboratory Informatics Market Size, 2019-2032 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
On the other hand, markets in the Europe and Asia Pacific regions are anticipated to witness a notable growth rate over the study period. During the forecast period, the European region is anticipated to grow at a CAGR of 7.75%, which is the second largest region amongst all the regions and touch the valuation of USD 0.92 billion in 2025. Key factors responsible for this include increasing data from research, advanced healthcare infrastructures, along with a rising number of strategic collaborations in the region. Backed by these factors, countries including the U.K. anticipate to record the valuation of USD 0.19 billion, Germany to record USD 0.22 billion, and France to record USD 0.17 billion in 2025. After Europe, the market in Asia Pacific is valued to reach USD 0.87 billion in 2025 and secure the position of third-largest region in the market. In the region, India and China both are estimated to reach USD 0.17 billion and USD 0.22 billion respectively in 2025.
Furthermore, the Latin America laboratory informatics market and the Middle East & Africa market are anticipated to witness a slower growth over the study period. The Latin America market in 2025 is set to record USD 0.20 billion as its valuation. Advancement in healthcare infrastructure is anticipated to drive the adoption of these products in these regions in the coming years. In the Middle East & Africa, GCC is set to attain the value of USD 0.09 billion in 2025.
Availability of Broad Product Portfolio coupled with Strong Geographical Presence of Leading Companies Supported their Dominating Position
The global market is moderately consolidated, with a mix of well-established players and specialized regional players. Leading companies such as Thermo Fisher Scientific, LabWare, and LabVantage Solutions dominate the market. This dominance can be attributed to their broad product portfolios, and strong global presence across various industries. Their strong integration capabilities, strategic collaborations with research institutions, and cloud-enabled offerings further strengthen their leadership positions.
Other key players include Dassault Systèmes, Core Informatics, and LabLynx. These companies are actively focusing on innovative product launches, and integration of AI and machine learning, and cloud-based deployments to expand their market presence.
To gain extensive insights into the market, Download for Customization
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2019-2032 |
|
Base Year |
2024 |
|
Forecast Period |
2025-2032 |
|
Historical Period |
2019-2023 |
|
Growth Rate |
CAGR of 7.64% from 2025-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Component
By Product
By Deployment
By Application
By End User
By Region
|
Fortune Business Insights says that the global market value stood at USD 4.11 billion in 2024 and is projected to reach USD 7.19 billion by 2032.
In 2024, the market value stood at USD 2.02 billion.
The market is expected to exhibit a CAGR of 7.64% during the forecast period.
The laboratory information management systems (LIMS) segment led the market by product.
The key factors driving the market include growing adoption of automation & digital transformation, and integration of AI, machine learning & analytics.
Thermo Fisher Scientific Inc., LabVantage Solutions Inc., and LabWare are some of the prominent players in the market.
North America dominated the market in 2024.
Growing R&D activities in life sciences & pharmaceuticals, and innovation in products are some of the factors that are expected to favor the product adoption.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )